The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Growth in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a significant growth in short interest in October. As of October 15th, there was short interest totaling 21,300 shares, a growth of 180.3% from the September 30th total of 7,600 shares. Based on an average daily trading volume, of 26,400 shares, the short-interest ratio is currently 0.8 days. Based on an average daily trading volume, of 26,400 shares, the short-interest ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ CGABL opened at $18.30 on Thursday. The stock’s fifty day simple moving average is $18.30 and its 200 day simple moving average is $17.59. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52-week low of $16.42 and a 52-week high of $19.96.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, August 1st were given a $0.2891 dividend. This represents a $1.16 annualized dividend and a dividend yield of 6.3%. The ex-dividend date of this dividend was Friday, August 1st.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.